Literature DB >> 17053543

Altered myogenic constriction and endothelium-derived hyperpolarizing factor-mediated relaxation in small mesenteric arteries of hypertensive subtotally nephrectomized rats.

Simone Vettoretti1, Peter Ochodnicky, Hendrik Buikema, Rob H Henning, C Alex Kluppel, Dick de Zeeuw, Richard P E van Dokkum.   

Abstract

OBJECTIVES: Chronic renal failure (CRF) is associated with altered systemic arterial tone and hypertension. Myogenic constriction and endothelium-derived hyperpolarizing factor (EDHF)-dependent relaxation represent major vasoregulatory mechanisms in small systemic arteries. Elevated myogenic response and impaired EDHF might participate in the development of essential hypertension; however, their role in CRF-related hypertension is unknown. We investigated whether myogenic response and EDHF are altered in subtotally nephrectomized (sNX) rats and whether these changes are modifiable by chronic treatment with angiotensin-converting enzyme (ACE) inhibitor.
METHODS: In a pressure arteriograph, myogenic constriction and EDHF-mediated relaxation were evaluated in small mesenteric arteries isolated from male Wistar rats 15 weeks after either sham operation (n = 7) (SHAM), sNX (n = 12) or sNX followed by 9 weeks of treatment with lisinopril (sNX + LIS, 2.5 mg/kg, n = 13).
RESULTS: Surprisingly, myogenic response was reduced in hypertensive CRF rats (maximal myogenic tone: 37 +/- 2 and 18 +/- 4%, P < 0.01; peak myogenic index: -0.80 +/- 0.08 and -0.40 +/- 0.12%/mmHg, P < 0.05 in SHAM and sNX respectively). At the same time EDHF-mediated relaxation was also impaired (maximal response: 92 +/- 2 and 77 +/- 5%, P < 0.01; pD2: 6.5 +/- 0.1 and 5.9 +/- 0.1, P < 0.05). Both myogenic response and EDHF were inversely related to the severity of renal failure and restored by treatment with lisinopril to levels found in SHAM animals.
CONCLUSION: Major constrictive (myogenic) and dilatory (EDHF) mechanisms of small systemic arteries are impaired in hypertensive CRF rats. These alterations do not seem to participate in the development of hypertension, being rather directly related to the severity of renal impairment. Both systemic vascular changes might be restored by renoprotective treatment with ACE inhibitor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17053543     DOI: 10.1097/01.hjh.0000249699.04113.36

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  10 in total

Review 1.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

Review 2.  Endothelial Ca+-activated K+ channels in normal and impaired EDHF-dilator responses--relevance to cardiovascular pathologies and drug discovery.

Authors:  Ivica Grgic; Brajesh P Kaistha; Joachim Hoyer; Ralf Köhler
Journal:  Br J Pharmacol       Date:  2009-03-19       Impact factor: 8.739

3.  Effects of pregnancy, hypertension and nitric oxide inhibition on rat uterine artery myogenic reactivity.

Authors:  Carolyn Barron; Maurizio Mandala; George Osol
Journal:  J Vasc Res       Date:  2010-04-30       Impact factor: 1.934

4.  Endothelial cell transfusion ameliorates endothelial dysfunction in 5/6 nephrectomized rats.

Authors:  Maricica Pacurari; Dongqi Xing; Rob H P Hilgers; Yuan Yuan Guo; Zhengqin Yang; Fadi G Hage
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-08-16       Impact factor: 4.733

Review 5.  Endothelium-Dependent Hyperpolarization (EDH) in Hypertension: The Role of Endothelial Ion Channels.

Authors:  Kenichi Goto; Toshio Ohtsubo; Takanari Kitazono
Journal:  Int J Mol Sci       Date:  2018-01-21       Impact factor: 5.923

6.  Skeletal vascular perfusion is altered in chronic kidney disease.

Authors:  Mohammad W Aref; Elizabeth A Swallow; Neal X Chen; Sharon M Moe; Matthew R Allen
Journal:  Bone Rep       Date:  2018-05-04

Review 7.  Retinal arterial hypertrophy: the new LVH?

Authors:  Kaivan Khavandi; Meena Arunakirinathan; Adam S Greenstein; Anthony M Heagerty
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

8.  Mechanisms of endothelial dysfunction in resistance arteries from patients with end-stage renal disease.

Authors:  Leanid Luksha; Peter Stenvinkel; Folke Hammarqvist; Juan Jesús Carrero; Sandra T Davidge; Karolina Kublickiene
Journal:  PLoS One       Date:  2012-04-26       Impact factor: 3.240

9.  Maintenance of hypertensive hemodynamics does not depend on ROS in established experimental chronic kidney disease.

Authors:  Diana A Papazova; Arianne van Koppen; Maarten P Koeners; Ronald L Bleys; Marianne C Verhaar; Jaap A Joles
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

10.  Spironolactone ameliorates endothelial dysfunction through inhibition of the AGE/RAGE axis in a chronic renal failure rat model.

Authors:  Chun-Cheng Wang; An-Sheng Lee; Shu-Hui Liu; Kuan-Cheng Chang; Ming-Yi Shen; Chiz-Tzung Chang
Journal:  BMC Nephrol       Date:  2019-09-06       Impact factor: 2.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.